Liquid Presentation

  • AAHI’s adjuvant formulations are stable for one to five years at refrigerated temperatures (4°C) and several months at elevated temperatures (25°C), depending on the adjuvant
  • AAHI-SC2, AAHI’s saRNA-NLC COVID-19 vaccine candidate, is stable at refrigerated temperatures (4°C) for one month and in ambient temperatures (25°C) for two weeks
x